Found: 19
Select item for more details and to access through your institution.
Inhibition of related JAK/ STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 667, doi. 10.1111/bjh.12308
- By:
- Publication type:
- Article
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-142
- By:
- Publication type:
- Article
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 998, doi. 10.1177/1078155218769367
- By:
- Publication type:
- Article
Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 8, p. 939, doi. 10.1007/s00277-011-1179-2
- By:
- Publication type:
- Article
Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4022, doi. 10.3390/cancers15164022
- By:
- Publication type:
- Article
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5169, doi. 10.3390/cancers14205169
- By:
- Publication type:
- Article
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1310, doi. 10.3390/cancers14051310
- By:
- Publication type:
- Article
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3189, doi. 10.3390/cancers13133189
- By:
- Publication type:
- Article
Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1662, doi. 10.3390/cancers13071662
- By:
- Publication type:
- Article
Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54407-4
- By:
- Publication type:
- Article
FLIP: A New Approach for Easing the Use of Federated Learning.
- Published in:
- Applied Sciences (2076-3417), 2023, v. 13, n. 6, p. 3446, doi. 10.3390/app13063446
- By:
- Publication type:
- Article
Functional characterization of the RAL-dependent survival pathway in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e138, doi. 10.1016/j.clml.2019.09.230
- By:
- Publication type:
- Article
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0283-8
- By:
- Publication type:
- Article
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Verde Macael: A Serpentinite Wrongly Referred to as a Marble.
- Published in:
- Geosciences (2076-3263), 2013, v. 3, n. 1, p. 102, doi. 10.3390/geosciences3010102
- By:
- Publication type:
- Article
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05683-4
- By:
- Publication type:
- Article
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. 112, doi. 10.1634/theoncologist.2019-0356
- By:
- Publication type:
- Article
Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1252258
- By:
- Publication type:
- Article
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter